Nature article focuses on tinnitus treatment

Millions affected by hearing disorder

2011-01-13

(Press-News.org) Targeted nerve stimulation could yield a long-term reversal of tinnitus, a debilitating hearing impairment affecting at least 10 percent of senior citizens and up to 40 percent of military veterans, according to an article posted in the Jan. 12 online edition of Nature.

Researchers Dr. Michael Kilgard and Dr. Navzer Engineer from The University of Texas at Dallas and University-affiliated biotechnology firm MicroTransponder report that stimulation of the vagus nerve paired with sounds eliminated tinnitus in rats. A clinical trial in humans is due to begin in the next few months.

Described as a ringing in the ears, tinnitus causes mild irritation for some people but is disabling and painful for many others. The U.S. Veterans Administration spends about $1 billion a year on disability payments for tinnitus, said Kilgard, associate professor in the School of Behavioral and Brain Sciences at UT Dallas and co-author of the journal article.

"Brain changes in response to nerve damage or cochlear trauma cause irregular neural activity believed to be responsible for many types of chronic pain and tinnitus," he said. "But when we paired tones with brief pulses of vagus nerve stimulation, we eliminated the physiological and behavioral symptoms of tinnitus in noise-exposed rats."

The researchers are, in essence, retraining the brain to ignore the nerve signals that simulate ringing. They monitored the laboratory rats for several weeks after therapy, and the improvements persisted.

"This minimally invasive method of generating neural plasticity allows us to precisely manipulate brain circuits, which cannot be achieved with drugs," said Dr. Navzer Engineer, vice president of preclinical affairs at MicroTransponder and lead author on the study. "Pairing sounds with VNS provides that precision by rewiring damaged circuits and reversing the abnormal activity that generates the phantom sound."

The research team is developing parameters for a clinical trial in humans. Vagus nerve stimulation (VNS) is currently used in humans for treatment of epilepsy and depression. "The translation from basic science to the clinic has been quite rapid," Engineer said. "It's exciting that the National Institutes for Health has been so supportive of our efforts to move this work along faster, in hopes of providing effective treatments to tinnitus patients."

The National Institutes of Health (NIH) early in 2010 granted Kilgard and MicroTransponder $1.7 million to further investigate whether nerve stimulation offers a long-term cure for tinnitus.

The first patient could be treated in Europe by early 2011, Engineer said. The initial set of human participants will have the electrodes attached to the left vagus nerve in their neck during a short outpatient procedure. They will come to the clinic Monday through Friday for a few weeks of treatment. At each daily session, they will experience VNS paired with sounds.

MicroTransponder, a neuroscience based medical device company, was founded by UT Dallas PhD candidate Will Rosellini and sponsored by the school's Institute for Innovation and Entrepreneurship. MicroTransponder is developing a less invasive wireless medical device to stimulate the vagus nerve. The UT Dallas/MicroTransponder team also is studying how best to optimize the paired therapy for tinnitus patients.

Past research has shown that the severity of chronic pain and tinnitus is tied to the degree of plasticity in the brain's cortex. A previous study showed that repeatedly pairing sensory stimuli with electrical stimulation of a brain structure called nucleus basalis generates powerful and long-lasting changes in cortical organization. Since the vagus nerve is easier to access for clinical use, and is known to trigger the release of molecules in the brain that promote neural changes, follow-up studies were performed on the vagus nerve.

For the VNS study, the research team used a "gap detection model" to document tinnitus in rats that were exposed to loud noise for one hour while under anesthesia. Each of the noise-exposed rats used in this study exhibited a significant impairment in the ability to detect a quiet gap in a tone near their tinnitus frequency, but exhibited no impairment when the gap was placed in a higher or lower tone.

"Previous research showed that a frequency-specific impairment in gap detection is a likely sign that noise-exposed rats experience a mid-frequency tinnitus 'ringing' that fills the silent gaps," Kilgard said. "Though it isn't possible to evaluate the subjective experience of rats, this gap impairment has been taken as an indicator of tinnitus."

When the rats were exposed to VNS paired with sounds, the gap impairment was eliminated – indicating that the tinnitus was gone.

Today's therapies for tinnitus have limited success and frequently must be modified over time because they become ineffective. "The VNS treatment would be an improvement over current therapies involving medications or counseling because it offers a possible permanent end to the condition and doesn't appear to cause any significant side effects," Kilgard said.

INFORMATION: Additional sponsors of the work include the James S. McDonnell Foundation, the Norman Hackerman Advanced Research Program and the Texas Emerging Technology Fund.

The paper's other authors were: UT Dallas neuroscientists Drs. Jonathan Riley, Jonathan Seale, Will Vrana, Jai Shetake, Sindhu Sudanagunta and Michael Borland. The article will be published in the Jan. 27 print edition of the journal.

ELSE PRESS RELEASES FROM THIS DATE:

Antibiotics best treatment for ear infections in toddlers, NIH grantees find

2011-01-13

WHAT: Adding new evidence to the debate on the best treatment for middle-ear infections, or acute otitis media, in young children, clinical researchers at the Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center have found antibiotics to be more effective than a placebo in relieving symptoms. These findings appear in the January 13th issue of the New England Journal of Medicine. The study was funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Most American children with middle-ear ...

Astronomers discover close-knit pairs of massive black holes

2011-01-13

PASADENA, Calif.—Astronomers at the California Institute of Technology (Caltech), University of Illinois at Urbana-Champaign (UIUC), and University of Hawaii (UH) have discovered 16 close-knit pairs of supermassive black holes in merging galaxies. The discovery, based on observations done at the W. M. Keck Observatory on Hawaii's Mauna Kea, is being presented in Seattle on January 12 at the meeting of the American Astronomical Society, and has been submitted for publication in the Astrophysical Journal. These black-hole pairs, also called binaries, are about a hundred ...

Scaling up: The future of nanoscience

2011-01-13

In the late 1950s, Richard Feynman famously imagined a science where researchers and engineers could achieve remarkable feats by manipulating matter and creating structures all the way down to the level of individual atoms. Now, over fifty years after "There's Plenty of Room at the Bottom," four prominent researchers -– David Awschalom, Angela Belcher, Donald Eigler, and Michael Roukes -– are sharing their thoughts about the future of nanoscience and nanotechnology. In a special dialogue ahead of a Kavli Futures Symposium on the same topic, the scientists focused on ...

Baby-led weaning is feasible but could cause nutritional problems for minority of infants

2011-01-13

Most babies can reach out for and eat finger food by six to eight months, according to a study in the January issue of Maternal and Child Nutrition. However baby-led weaning - which advocates babies feeding themselves solid foods, rather than being spoon fed purees - could lead to nutritional problems for the small number of children who develop later than average. That is why UK researchers - led by child health specialist Professor Charlotte M Wright from the University of Glasgow, Scotland - recommend combining self-feeding with solid finger food with traditional ...

Study sheds new light on river blindness parasite

2011-01-13

The team found that a bacterium inside the worm acts as a 'disguise' for the parasite, resulting in the immune system reacting to it in an ineffective way. The bacteria protect the worm from the body's natural defences, but once the bacteria are removed with antibiotics, the immune system responds appropriately, releasing cells, called eosinophils, that kill the worm. Antibiotics are successful against the parasite, but the long treatment regime means that it has limited use across whole communities. These new findings suggest that if medics could prime the immune ...

Sleep mode: The energy cost of sleep deprivation

2011-01-13

The findings show that missing a night of sleep burns roughly 135 calories, the equivalent of two slices of bread or a 225 ml glass of semi-skimmed milk. In terms of physical exertion, this amounts to walking just under two miles. On the flip side, eight hours of sleep saved the same approximate amount of energy. 'While the amount of energy saved during sleep may seem small, it was actually more than we expected,' says Professor Kenneth Wright, lead author of the study and Director of Colorado University's Sleep and Chronobiology Laboratory. 'If one considers the amount ...

The 'Spaser' heats up laser technology

2011-01-13

Lasers have revolutionized the communications and medical industries. They focus light to zap tumors and send digital TV signals and telephone communications around the world. But the physical length of an ordinary laser cannot be less than one half of the wavelength of its light, which limits its application in many industries. Now the Spaser, a new invention developed in part by Tel Aviv University, can be as small as needed to fuel nano-technologies of the future. Prof. David Bergman of Tel Aviv University's Department of Physics and Astronomy developed and patented ...

Adrenaline receptor 'frozen in action' by VIB researchers

2011-01-13

Brussels - Adrenaline, the hormone that prepares our body to fight or flight, acts on a hyperdynamic receptor. This molecule switches so fast between several positions, that it was impossible to image it. Until now. Scientists, including Jan Steyaert of VIB and the Vrije Universiteit Brussel in Belgium, and colleagues from Stanford University in the US, have "frozen the molecule in action" using Xaperones™, tiny, stable antibodies developed by the Brussels scientists. The Xaperones™ bind like a key to a lock, holding the adrenaline receptor in one position -- the on position. ...

Origins of the pandemic: Study reveals lessons of H1N1

2011-01-13

As H1N1 'Swine Flu' returns to the national headlines a new research paper reveals the key lessons about the origins of the 2009 pandemic. The paper, published today in BioEssays, reveals how the pandemic challenges the traditional understanding of 'antigenic shift' , given that the virus emerged from an existing influenza subtype. "H1N1 emerged in February 2009 in Mexico and swept around the globe within 6 months." said Professor Hans Dieter Klenk from Philipps-Universität Marburg. "The conventional ideal is that pandemics are fuelled by new strands which emerge in the ...

New approach to modeling power system aims for better monitoring and control of blackouts

2011-01-13

Major power outages are fairly infrequent, but when they happen they can result in billions of dollars in costs – and even contribute to fatalities. Now research from North Carolina State University has led to the development of an approach by which high-resolution power-system measurements, also referred to as Synchrophasors, can be efficiently used to develop reliable models of large power systems, which would help us keep an eye on their health. Synchrophasors are real-time measurements of voltages and currents that provide a very high-resolution view of various complex ...

LAST 30 PRESS RELEASES:

How stepping into nature affects the brain

Study: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer

The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds